Annual results
No Comments
Net loss for the Group of €11.1 million in 2020, an improvement of €1.6 million compared to 2019. Gross cash position of €15.2 million as of 15 March 2021. …
Read More First renewable gasoline sample delivered to Audi
Everything you need to know
about the Global Bioenergies group
Global Bioenergies at a glance
Global Bioenergies has developed a process to convert plant-derived resources into a key family of ingredients used in the cosmetics industry. The process was first developed in a laboratory, where the Company is further enhancing performance.
It now operates as a pilot and a demo plant, with sufficient capacity to enable the Company to access the market by first creating a long-lasting makeup home brand.
The Company is gradually increasing its production capacities and is looking to improve the environmental footprint of not only the cosmetics industry but also that of other areas such as transportation and materials. Global Bioenergies is listed on Euronext Growth Paris (FR0011052257 – ALGBE)
Since 2008, Global Bioenergies has been
developing a process for transforming plant-based feedstocks
into cosmetic ingredients and aviation fuel.
Global Bioenergies in the news
Global Bioenergies opens new offices in Paris to prepare for the launch of its own range of cosmetic products
Evry, 2 March 2021 – Global Bioenergies (ALGBE) announces that it has moved certain support functions to premises located near Châtelet in Paris. These offices are also intended to accommodate…
Read More Release of the first batch of cosmetic-grade renewable isododecane
Evry, 14 January 2021 – Global Bioenergies releases its first commercial batch of cosmetic-grade renewable isododecane and confirms its use in the field of long-lasting makeup, in particular with the…
Read More Annual figures and changes to the Board of Directors
Net loss for the Group of €12.7m in 2019, an improvement of €0.9m compared to 2018 Cash position of €16.6 million at 31 December 2019 Ms. Corinne Granger joins the…
Read More Development in four stages
Proof of concept
To begin with, Global Bioenergies successfully set up a laboratory-scale prototype to provide proof of concept for its technology.
Laboratory development
Secondly, after its IPO on the Alternext market, the Company refined its process on a laboratory scale.
Industrialization
Stage 3, which began when €23 million in funds were raised in mid-2013, was devoted to industrialization.
Commercialization
From 2021, Global Bioenergies can switch millions of longwear makeup products to naturalness, partly marketed under its own brand.
Ecosystem
Timeline
Joint-Venture avec Cristal Union
First isobutene delivery to Arkema
Prêt de 4,4M€ d’un consortium de banque française, démarrage de la construction du démonstrateur en Allemagne
Successful completion of the first isobutene test at its Pomacle-Bazancourt industrial pilot
Start-up of the industrial pilot
Partnership with Audi to develop a drop-in biofuel
€5.2 million in funding under the Investissements d’Avenir program
Partenariat avec ARKEMA et le CNRS
Synthos establishes a stake for €2.7 million
Laboratory prototype
Our releases / medias
Press Releases
Global Bioenergies opens new offices in Paris to prepare for the launch of its own range of cosmetic products
Evry, 2 March 2021 – Global Bioenergies (ALGBE) announces that it has moved certain support functions to premises located near Châtelet in Paris. These offices are also intended to accommodate…
Read More Release of the first batch of cosmetic-grade renewable isododecane
Evry, 14 January 2021 – Global Bioenergies releases its first commercial batch of cosmetic-grade renewable isododecane and confirms its use in the field of long-lasting makeup, in particular with the…
Read More €3.1 million from ADEME to move forward on the IBN-One plant project
Evry (France), 2 October 2019 Global Bioenergies will soon be receiving €2.6 million and IBN-One €0.5 million in the form of repayable advances, following last July’s achievement of a technical…
Read More Changes to the Board of Directors
Evry (France), 05 September 2019 Further to today’s Annual General Meeting, Global Bioenergies announced that BOLD Business Opportunities for L’Oréal Development, now the largest shareholder following the financing transaction of last…
Read More Pierre Lévi and Alain Fanet join the Board of Directors
Evry (France), 18 April 2019 As today’s General Meeting of Shareholders came to an end, Global Bioenergies announced the election of two new independent directors to the Board: Pierre Lévi,…
Read More 2.2 million euros paid to Global Bioenergies after the first term of the OPTISOCHEM European project
Evry (France), 9 April 2019 – Global Bioenergies (Euronext Growth: ALGBE) has announced having received a payment of €2.2 million for the OPTISOCHEM project supported by the Bio-Based Industries Joint…
Read More Global Bioenergies greets the French parliament’s proposal aiming to promote a French bio-jet fuel industry
Evry (France), 13 March 2019 – Global Bioenergies (Euronext Growth: ALGBE) greets the proposal made by France’s parliament to establish a public support programme to promote the emerging French bio-jet…
Read More Butagaz and Global Bioenergies announce their first delivery of bio isobutene, a bio-sourced gas, to the Héraclès Winery
On 12 March 2019, the Héraclès Winery, France’s first ecological smart winery was able to take advantage of the first ever delivery containing bio-isobutene, a highly innovative bio-sourced gas. …
Read More First production of isobutene from wheat straw at demo scale
New phase for the H2020 Optisochem project after 18 months of activity Sugars from wheat straw produced at Clariant’s Sunliquid® pre-commercial plant have been shipped to Global Bioenergies’ Leuna demo…
Read More Global Bioenergies receives letters of intent for purchases covering the capacity of its first plant project, IBN-One, a joint venture with Cristal Union.
Evry (France), 27 November 2018 – Global Bioenergies (Euronext Growth: ALGBE) today announced signature of thirteen letters of intent from French and international industrial leaders for purchases totalling 49,000 to…
Read More Financial Press
Annual results
Net loss for the Group of €11.1 million in 2020, an improvement of €1.6 million compared to 2019. Gross cash position of €15.2 million as of 15 March 2021. …
Read More Annual figures and changes to the Board of Directors
Net loss for the Group of €12.7m in 2019, an improvement of €0.9m compared to 2018 Cash position of €16.6 million at 31 December 2019 Ms. Corinne Granger joins the…
Read More Global Bioenergies reduces its loss
Evry (France), 17 October 2019 – Publication of half-year financial statements as at 30 June 2019, audited and adopted by the Board of Directors at today’s meeting. The report for…
Read More Half-year report on the liquidity contract as of 28/06/2019
Evry (France) – 26 July 2019 – Global Bioenergies (Alternext Paris: ALGBE) presents the half-year report on the liquidity contract entrusted to the brokerage firm Gilbert Dupont. The following assets…
Read More A Shareholders’ Meeting will be held on 5 September 2019
Evry (France), 25 July 2019 – Global Bioenergies has announced that it will hold a shareholder’s meeting on 5 September 2019 at 3pm at its offices located at 5, rue…
Read More Success of the €17m capital increase
Evry (France), on 26 June 2019 Global Bioenergies (the “Company“) announces today having successfully closed its capital increase, launched on 20 June 2019 and conducted through a public offer without…
Read More Launch of a capital increase through a public offer without preferential subscription rights for an initial amount of €17 million supported by the L’Oréal Group and the CM-CIC funds
Participate Capital increase without preferential subscription rights and without priority subscription period through a public offer of an initial amount of €17 million, that may be increased up to €5…
Read More 2018 financial figures
Net loss for the Group of €13.6m in 2018, of which €2.9m in amortisation of the demo plant Cash position of €10.3m at 31 December 2018 Evry (France), 1…
Read More Full-year report on the liquidity contract as of 31/12/2018
Evry (France) – 25 January 2019 – Global Bioenergies (Euronext Growth : ALGBE) presents the full-year report on the liquidity contract entrusted to the brokerage firm Gilbert Dupont. The following assets appeared…
Read More Global Bioenergies to Present at Lytham Partners Virtual Investor Conference Event to take place on Tuesday, October 30, 2018
New York (United States) and Evry (France) October 24th, 2018 – Global Bioenergies (Euronext Growth: ALGBE) a leader in industrial biotechnology developing a process to convert renewable resources into hydrocarbons…
Read More 